Levetiracetam Axcount (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which plays a crucial role in the release of neurotransmitters. This binding modulates calcium‑dependent exocytosis, stabilising neuronal membranes and lowering the likelihood of excessive neuronal firing that leads to seizures.

The appropriate dose of Levetiracetam Axcount is determined by the prescribing clinician based on the patient’s age, weight, renal function and seizure type. Dosage adjustments may be required for special populations, and the regimen should always follow the prescriber’s instructions.

Safety data for levetiracetam in pregnancy and lactation are limited. The prescriber will weigh potential benefits against possible risks to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Levetiracetam differs from many traditional antiepileptics because it does not act through major cytochrome P450 enzymes, resulting in fewer drug‑drug interactions. Its unique SV2A binding provides effective seizure control with a generally favorable tolerability profile compared with older agents such as carbamazepine or phenytoin.

Levetiracetam Axcount should be stored at ambient temperature, below 25 °C. Keep the tablets in their original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Levetiracetam Axcount is taken orally, usually with or without food, as directed by the prescriber. Tablets are swallowed whole with a glass of water. The exact frequency and timing depend on the individual treatment plan established by the healthcare professional.

Serious risks include severe allergic reactions such as Stevens‑Johnson syndrome, significant mood changes like depression or suicidal thoughts, and rare blood disorders. Patients should seek immediate medical attention if they experience rash, swelling, mood alterations, or signs of infection.

Levetiracetam is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is advised for patients with severe renal impairment, uncontrolled psychiatric conditions, or those taking interacting medications that may diminish its effectiveness.